Jonathan P. DiVincenzo's most recent trade in Bio-Rad Laboratories Inc. - Ordinary Shares - Class A was a trade of 1,869 Restricted Stock Units done . Disclosure was reported to the exchange on Oct. 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Rad Laboratories Inc (Class A) | Jonathan P. DiVincenzo | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Oct 2025 | 1,869 | 5,609 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Jonathan P. DiVincenzo | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Oct 2025 | 1,869 | 1,869 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc (Class A) | Jonathan P. DiVincenzo | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 339.75 per share. | 24 Oct 2025 | 950 | 919 (0%) | 0% | 339.8 | 322,763 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc (Class A) | Jonathan P. DiVincenzo | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2025 | 6,850 | 6,850 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Jonathan P. DiVincenzo | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 4,863 | 4,863 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc (Class A) | Jonathan P. DiVincenzo | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 7,478 | 7,478 | - | - | Restricted Stock Units | |
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 21 Feb 2024 | 500 | 3,400 (0%) | 0% | 215.5 | 107,745 | Common Stock | |
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 11 Feb 2024 | 201 | 3,959 (0%) | 0% | - | Common Stock | ||
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 11 Feb 2024 | 201 | 4,977 | - | - | Restricted Stock Unit | ||
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 11 Feb 2024 | 59 | 3,900 (0%) | 0% | 227.5 | 13,420 | Common Stock | |
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 06 Feb 2024 | 3,000 | 3,000 | - | - | Non-qualified Stock Options | ||
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 06 Feb 2024 | 980 | 5,540 | - | - | Restricted Stock Unit | ||
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 06 Feb 2024 | 224 | 5,316 | - | - | Restricted Stock Unit | ||
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 06 Feb 2024 | 224 | 3,739 (0%) | 0% | - | Common Stock | ||
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 06 Feb 2024 | 138 | 5,178 | - | - | Restricted Stock Unit | ||
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 06 Feb 2024 | 138 | 3,799 (0%) | 0% | - | Common Stock | ||
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 06 Feb 2024 | 78 | 3,661 (0%) | 0% | 223.7 | 17,449 | Common Stock | |
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 06 Feb 2024 | 41 | 3,758 (0%) | 0% | 223.7 | 9,172 | Common Stock | |
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 02 Feb 2024 | 246 | 3,600 (0%) | 0% | - | Common Stock | ||
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 02 Feb 2024 | 246 | 4,560 | - | - | Restricted Stock Unit | ||
| Labcorp | Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | 02 Feb 2024 | 85 | 3,515 (0%) | 0% | 221.5 | 18,831 | Common Stock |